Brind.

Novartis and Novo Nordisk experienced simultaneous major drug program failures on September 14, 2026.

1 report, 1 independent Updated Sep 14

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Novartis Novo Nordisk

Keep exploring

The entities involved

Novartis
Swiss-American multinational pharmaceutical corporation
- Biotech and pharmaceutical companies in Greater Boston are seeing strategic investments, talent movement, and antibody development advances.Tue 13:27
Novo Nordisk
Danish pharmaceutical company
- Novo Nordisk and Astellas Pharma are noted as large-cap healthcare companies, with Novo Nordisk reporting higher revenue and earnings.18:20
- Omnicom Group secured new mandates and account extensions from CVS Health, L'Oréal, Mercedes-Benz, and Novo Nordisk.12:38

Related events

Coverage

Newest first; wire copies grouped

Sep 14medicaldaily.com